Thrombin receptor: An endogenous inhibitor of inflammatory pain, activating opioid pathways
Authors:
- Céline AugéCACéline Augé
- Jérôme BouéJBJérôme Boué
- Michelle C. BuresiMBMichelle C. Buresi
- Kevin ChapmanKCKevin Chapman
- Samuel AsfahaSASamuel Asfaha
- Patricia Andrade-GordonPAPatricia Andrade-Gordon
- Martin SteinhoffMSMartin Steinhoff
- Nicolas CenacNicolas Cenac
- Gilles DietrichGDGilles Dietrich
- Nathalie VergnolleNVNathalie Vergnolle
- 1 November 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Pain
- Vol. 146 (1) , 121-129
Abstract
Serine proteases such as thrombin, trypsin and mast cell tryptase can act on different cell types through protease-activated receptors (PARs). These receptors have been shown to be implicated in several phenomena such as inflammation, platelet activation, immune response and atherosclerosis. Several studies recently reported PARs expression on neurons and some of them demonstrated that these receptors could interfere with nociception. The contribution of PAR(1) to inflammatory pain and the mechanism involved in this phenomenon were investigated. Intraplantar injection of PAR(1) agonist increased withdrawal latency and reduced response frequency to von Frey filaments, thus inhibiting nociceptive response to both mechanical and thermal stimuli in mice. PAR(1) agonist also reduced carrageenan-induced inflammatory hyperalgesia. The anti-nociceptive effects of PAR(1) agonist were mediated by endogenous opioids, as this effect was inhibited by local injection of naloxone methiodide, and because intraplantar injection of PAR(1) agonist increased mRNA expression of the endogenous opioid precursor proenkephalin. However, PAR(1) agonist was not able to inhibit calcium signals in isolated sensory neurons exposed to pro-nociceptive agents. Finally, despite similar inflammatory parameters, PAR(1)-deficient mice showed a strong potentiation of inflammatory hyperalgesia induced by the intraplantar injection of either formalin or carrageenan, or in the chronic model of collagen-induced arthritis, compared to wild-type mice. This study highlights a previously unknown endogenous mechanism of analgesia, showing a central role for the thrombin receptor PAR(1) in the regulation of inflammatory pain and as an activator of opioid pathways.Keywords
This publication has 27 references indexed in Scilit:
- Protease Signaling to G Protein-Coupled Receptors: Implications for Inflammation and PainJournal of Receptors and Signal Transduction, 2008
- Role for protease activity in visceral pain in irritable bowel syndromeJournal of Clinical Investigation, 2007
- Protease‐activated receptor‐4: a novel mechanism of inflammatory pain modulationBritish Journal of Pharmacology, 2007
- Protease‐activated receptors in hemostasis, thrombosis and vascular biologyJournal of Thrombosis and Haemostasis, 2005
- Proteinase‐activated receptor‐1 agonists attenuate nociception in response to noxious stimuliBritish Journal of Pharmacology, 2002
- Agonists of proteinase‐activated receptor 1 induce plasma extravasation by a neurogenic mechanismBritish Journal of Pharmacology, 2001
- Distribution and potential biologic function of the thrombin receptor PAR-1 on human keratinocytesArchives of Dermatological Research, 2000
- How the protease thrombin talks to cellsProceedings of the National Academy of Sciences, 1999
- Thrombin and mast cell tryptase regulate guinea‐pig myenteric neurons through proteinase‐activated receptors‐1 and −2The Journal of Physiology, 1999
- Proenkephalin is a nuclear protein responsive to growth arrest and differentiation signals.Journal of Cell Biology, 1995